Patents by Inventor Swargam Sathyanarayana

Swargam Sathyanarayana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SORAFENIB ETHYLSULFONATE SALT, PROCESS FOR PREPARATION AND USE
    Publication number: 20130005777
    Abstract: The present invention provides sorafenib ethane sulphonate, process for its preparation, pharmaceutical composition comprising sorafenib ethane sulphonate and its use for the treatment of cancer. Formula (III).
    Type: Application
    Filed: November 12, 2010
    Publication date: January 3, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESSES FOR THE PREPARATION OF ERLOTINIB HYDROCHLORIDE FORM A AND ERLOTINIB HYDROCHLORIDE FORM B
    Publication number: 20120302749
    Abstract: The present invention relates to processes for the preparation of erlotinib hydrochloride Form A and erlotinib hydrochloride Form B. (I).
    Type: Application
    Filed: November 12, 2010
    Publication date: November 29, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Balaguru Murugesan, Anandam Vempali, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM I OF L-MALIC ACID SALT OF SUNITINIB
    Publication number: 20120271056
    Abstract: The present invention relates to a process for the preparation of crystalline Form I of the L-malic acid salt of sunitinib.
    Type: Application
    Filed: November 12, 2010
    Publication date: October 25, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sudhir Singh Sanwal, Saridi Madhava Dileep Kumar, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • POLYMORPHS OF SORAFENIB ACID ADDITION SALTS
    Publication number: 20120264789
    Abstract: The present invention provides amorphous and crystalline forms of acid addition salts of sorafenib, pharmaceutical compositions comprising them and their use for the treatment of cancer. The present invention also provides processes for the preparation of acid addition salts of sorafenib.
    Type: Application
    Filed: September 24, 2010
    Publication date: October 18, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF A CRYSTALLINE FORM OF LENALIDOMIDE
    Publication number: 20120220777
    Abstract: The present invention relates to an in-situ process for the preparation of polymorphic Form A of lenalidomide.
    Type: Application
    Filed: September 16, 2010
    Publication date: August 30, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Saridi Madhava Dileep Kumar, Munish Kapoor, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • SALTS OF SUNITINIB
    Publication number: 20120220783
    Abstract: The present invention relates to salts of sunitinib and their preparation.
    Type: Application
    Filed: September 16, 2010
    Publication date: August 30, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sudhir Singh Sanwal, Saridi Madhava Dileep Kumar, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF LENALIDOMIDE
    Publication number: 20120184746
    Abstract: The present invention relates to a process for the preparation of lenalidomide, wherein the process comprises: reducing 3-(4-nitro-loxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione to obtain lenalidomide.
    Type: Application
    Filed: September 3, 2010
    Publication date: July 19, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Munish Kapoor, Saridi Madhava Dileep Kumar, Balaguru Murugesan, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF DESLORATADINE
    Publication number: 20120101281
    Abstract: The present invention provides a process for the preparation of desloratadine comprising contacting loratadine with a mixture of a weak inorganic base and sodium or potassium hydroxide in a ratio, ranging from 0.01 to 0.15 equivalents of sodium or potassium hydroxide per equivalent of weak inorganic base, in one or more suitable solvents) followed by isolation.
    Type: Application
    Filed: March 26, 2010
    Publication date: April 26, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Balaguru Murugesan, Swargam Sathyanarayana, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF ERLOTINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    Publication number: 20120101272
    Abstract: The present invention relates to a process for preparation of erlotinib of Formula I or its pharmaceutically acceptable salt thereof. The present invention also relates to process for the preparation of erlotinib trifluoroacetate. The present invention also relates to a nove-ICrystalline form of erlotinib trifluoroacetate designated as Form E and process for its preparation. The present invention further relates to process for the preparation of erlotinib hydrochloride from erlotinib trifluoroacetate.
    Type: Application
    Filed: March 26, 2010
    Publication date: April 26, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Balaguru Murugesan, Anandam Vempali, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Process for the production of atorvastatin calcium in amorphous form
    Patent number: 7994343
    Abstract: A process for the production of amorphous atorvastatin calcium and stabilized, amorphous atorvastatin calcium is provided.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: August 9, 2011
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Yatendra Kumar, Saridi Madhava Dileep Kumar, Swargam Sathyanarayana
  • MAGNESIUM SALTS OF HMG-COA REDUCTASE INHIBITORS
    Publication number: 20100222405
    Abstract: The present invention relates to magnesium salts of HMG-CoA reductase inhibitors, processes for their preparation, pharmaceutical compositions thereof and methods of using compositions to treat mammals suffering from hypercholesterolemia.
    Type: Application
    Filed: May 3, 2006
    Publication date: September 2, 2010
    Inventors: Yatendar Kumar, Saridi Madhava Kumar, Swargam Sathyanarayana
  • CRYSTALLINE FORMS OF ATORVASTATIN MAGNESIUM
    Publication number: 20090306173
    Abstract: The present invention relates to crystalline forms of Atorvastatin magnesium and processes for their preparation. The crystalline forms of the present invention are designated as form X, form Y, form Z and form P of atorvastatin magnesium. The present invention further relates to pharmaceutical compositions comprising form X, form Y, form Z and form P of atorvastatin magnesium and method of using the crystalline forms.
    Type: Application
    Filed: June 2, 2009
    Publication date: December 10, 2009
    Inventors: Vipin TYAGI, Wajid Sajjad Jafri, Sanjay Kumar, Saridi Madhava Dileep Kumar, Swargam Sathyanarayana, Kaptan Singh, Mohan Prasad
  • PROCESS FOR THE PRODUCTION OF ATORVASTATIN CALCIUM IN AMORPHOUS FORM
    Publication number: 20090216029
    Abstract: A process for the production of amorphous atorvastatin calcium and stabilized, amorphous atorvastatin calcium is provided.
    Type: Application
    Filed: February 21, 2008
    Publication date: August 27, 2009
    Inventors: Yatendra KUMAR, Saridi Madhava Dileep Kumar, Swargam Sathyanarayana
  • Process for the preparation of rosuvastatin
    Patent number: 7566782
    Abstract: The present invention relates to a process for the preparation of rosuvastatin calcium, a promising new HMG-CoA reductase inhibitor.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: July 28, 2009
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Yatendra Kumar, Hashim Nizar Poovanathil Nagoor Meeran, Shantanu De, Mohammad Rafeeq, Swargam Sathyanarayana
  • PACKAGING FOR AMORPHOUS STATINS AND COMPOSITIONS THEREOF
    Publication number: 20090071855
    Abstract: The present publication relates to a vacuum-sealed pack comprising an amorphous statin or a pharmaceutical composition thereof and at least one stabilizer such as, for example, an oxygen absorber, a moisture absorber or a combination thereof.
    Type: Application
    Filed: September 14, 2007
    Publication date: March 19, 2009
    Inventors: Sumit BAHUGUNA, Anindya Munshi, Rajeev Shankar Mathur, Swati Aggarwal, Romi Barat Singh, Swargam Sathyanarayana, Saridi Madhava Kumar
  • SALTS OF HMG-COA REDUCTASE INHIBITORS AND USE THEREOF
    Publication number: 20090036680
    Abstract: The present invention relates to salts of HMG CoA reductase inhibitors, and in particular, rosuvastatin amine salts and their use as intermediates in the preparation of rosuvastatin calcium.
    Type: Application
    Filed: January 19, 2005
    Publication date: February 5, 2009
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Yatendra Kumar, Mohammad Rafeeq, Shantanu De, Swargam Sathyanarayana
  • Novel Processes for Preparing Amorphous Rosuvastatin Calcium and a Novel Polymorphic Form of Rosuvastatin Sodium
    Publication number: 20080234302
    Abstract: Provided are processes for preparing amorphous rosuvastatin calcium from crystalline rosuvastatin calcium by simple precipitation processes. Also provided is a novel polymorphic form of rosuvastatin sodium, processes for preparing thereof and pharmaceutical compositions thereof.
    Type: Application
    Filed: September 20, 2005
    Publication date: September 25, 2008
    Inventors: Mohammad Rafeeq, Shantanu De, Swargam Sathyanarayana, Yatendra Kumar
  • PROCESS FOR THE PREPARATION OF DESLORATADINE
    Publication number: 20070244144
    Abstract: The present invention relates to an improved process for the preparation of Form 1 of desloratadine essentially free of Form 2. The invention also relates to Form 1 of desloratadine substantially free of Form 2, process for its preparation, pharmaceutical composition comprising it and its method of use for the treatment of allergic reactions in mammals.
    Type: Application
    Filed: April 10, 2007
    Publication date: October 18, 2007
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Deepak MURPANI, Mohammad RAFEEQ, Praveen RAHEJA, Swargam SATHYANARAYANA, Mohan PRASAD
  • Process for the preparation of amorphous rosuvastatin calcium
    Publication number: 20070191318
    Abstract: The invention relates to processes for the preparation of amorphous rosuvastatin calcium. More particularly, it relates to the preparation of pure amorphous rosuvastain calcium and pharmaceutical compositions that include the pure amorphous rosuvastatin calcium. The invention also relates to use of said compositions for treating hyperlipidemia, hypercholesterolemia, and atherosclerosis. Formula (I).
    Type: Application
    Filed: October 22, 2004
    Publication date: August 16, 2007
    Inventors: Yatendra Kumar, Mohammad Rafeeq, Shantanu De, Swargam Sathyanarayana
  • Process for the preparation of rosuvastatin
    Publication number: 20060149065
    Abstract: The present invention relates to a process for the preparation of rosuvastatin calcium, a promising new HMG-CoA reductase inhibitor.
    Type: Application
    Filed: December 10, 2002
    Publication date: July 6, 2006
    Inventors: Yatendra Kumar, Hashim Nizar Poovanathil Neeran, Shantanu De, Mohammed Rafeeq, Swargam Sathyanarayana